PATENT CLAIM ANALYSIS

Application Number: 15917371
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-09
Patent Classification: ["514", "025000"]

Abstract:
The invention provides medicaments comprising an oenothein, including oral formulations to treat inflammation or to treat hormone balance in perimenopausal, menopausal and postmenopausal women. The oenothein for use in such formulations such as oenothein A or oenothein B maybe purified from natural sources, such as  Epilobium.

Claim (Index 16):
The method of  claim 1  or  14 , wherein the oenothein is extracted or prepared from a plant source other than New World  Epilobium parviflorum.

Metadata:
- Claim Count in Document: 1.0
- Percentile: 90.0
- Lexical Diversity: 1.41667
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15305591', '14907497', '15328706', '14266382', '13725381']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7450841472322911
- 35 USC 102 Novelty (BERT): 0.4914295717324731
- Combined Prediction Score: 0.7197186896823093
- Mean Citation Score: 170.1797
- Max Citation Score: 203.41833
- Similarity Product: 144.79517576134444

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test